Key features
- Stroke AI: real-time analysis of CT and CTA images detecting large vessel occlusion stroke with automated NIHSS estimation — alert sent to neurology and interventional team before radiologist review
- Pulmonary embolism AI: CT pulmonary angiography analysis detecting PE with risk stratification — automated notification to the appropriate care team for expedited treatment
- Haemorrhage detection: CT analysis detecting intracranial haemorrhage with volume estimation — acute care workflow support for emergency neurosurgery decisions
- Aortic dissection: CT aorta analysis detecting Type A and B aortic dissection — time-critical condition where AI detection speed is directly correlated with treatment outcomes
- Care coordination hub: secure specialist messaging platform that consolidates all AI alerts, imaging, and clinical communication in one mobile application for the on-call care team
- Analytics dashboard: hospital-level and department-level analytics on AI alert volume, response times, treatment decisions, and outcomes — enables clinical leadership to quantify the impact of AI care coordination
Best for
- APAC public and private hospitals with stroke centres, catheter labs, or vascular surgery capabilities that want to reduce door-to-treatment time for large vessel occlusion stroke — every minute of delay in stroke treatment is associated with measurable outcome degradation
- APAC regional hospitals and community hospitals that receive emergency CT scans but transfer time-critical patients to tertiary centres — Viz.ai enables remote specialist review and earlier transfer decisions
- APAC hospital radiology departments experiencing overnight and weekend radiologist coverage gaps — AI detection alerts ensure specialists are notified for critical findings outside normal working hours without waiting for radiologist review
- APAC healthcare systems evaluating AI-assisted clinical decision support in high-acuity settings where clinical evidence of AI benefit is established (stroke, PE, haemorrhage) and regulatory clearance pathways are defined
Limitations to know
- ! Regulatory clearance status: Viz.ai has FDA and CE Mark clearances; APAC regulatory clearances (Australia TGA, Singapore HSA, Japan PMDA) should be verified for specific product modules before clinical deployment — status varies by country and indication
- ! Integration prerequisites: Viz.ai requires integration with PACS (Picture Archiving and Communication System) for image routing — APAC hospitals with older or non-standard PACS infrastructure should assess integration complexity
- ! Clinical workflow change: AI care coordination changes on-call workflows and specialist notification patterns; implementation requires physician and administrator engagement to redesign alert response protocols
- ! Scope: Viz.ai is focused on specific time-critical conditions (stroke, PE, haemorrhage, aortic dissection); it is not a general radiology AI platform — hospitals wanting broader radiology AI coverage need additional solutions for outpatient and non-emergency imaging
Beyond this tool
Where this category meets practice depth.
A tool only matters in context. Browse the service pillars that operationalise it, the industries where it ships, and the Asian markets where AIMenta runs adoption programs.
Other service pillars
By industry